Michael S. Abrams

Chief Financial Officer, FITLIFE BRANDS, INC.

Companies

NRX Pharmaceuticals, Inc.Chief financial officer Nov 22, 2024 to now¹
Arch Therapeutics, Inc.Chief financial officer May 10, 2021 to Sep 8, 2023²
FITLIFE BRANDS, INC.Board member Mar 30, 2011 to Feb 14, 2017³
FITLIFE BRANDS, INC.Chief financial officer Aug 30, 2010 to Feb 14, 2017⁴
QUANTRX BIOMEDICAL CORPBoard member Mar 1, 2012 to Mar 1, 2012⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arch Therapeutics, Inc.10,292 shares⁶Aug 31, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 31, 2023Bought 10,292 shares at $0.28 of Arch Therapeutics, Inc.⁶
Jul 6, 2022Granted 108,652 shares of Arch Therapeutics, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNRX Pharmaceuticals, Inc., Chief financial officer
2
SEC EDGARArch Therapeutics, Inc., Chief financial officer
3
SEC EDGARFITLIFE BRANDS, INC., Board member
4
SEC EDGARFITLIFE BRANDS, INC., Chief financial officer
5
SEC EDGARQUANTRX BIOMEDICAL CORP, Board member
6
SEC EDGARArch Therapeutics, Inc. shares after the filing of Aug 31, 2023
7
SEC EDGARForm 4 filed Jul 8, 2022